Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,054.80
(
-0.57%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.85
(
2.20%
)
Bitcoin
77,338.00
(
-1.15%
)
News Focus
News Focus
Post# of 822500
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Doc logic

Send PM Follow Ignore
Followers 177
Posts 16210
Boards Moderated 1
Alias Born 01/26/2016

Doc logic

Re: exwannabe post# 559652

Tuesday, 01/17/2023 12:22:52 PM

Tuesday, January 17, 2023 12:22:52 PM

Post# of 822500
exwannabe,

Was every patient from the trials used to develop the ECAs included? Want to take a guess as to why or why not? Multiple factors were used to match patients right? Maybe that’s why what you are talking about is not an issue apart from the fact that the ECAs had greater multiples of actual patients being compared and still had no long term patients in almost all categories vs those receiving treatment with L. Beating hearts matter and the JAMA peer review confirmed this rather obvious fact ; ). Best wishes.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News